121 related articles for article (PubMed ID: 5030544)
1. Acetylene compounds of potential pharmacological value. XVI. N-(perhydroazepinoalkynyl)- and N-(perhydroazocinoalkynyl)succinimides.
Lindquist A; Lindgren S; Lindeke B; Karlén B; Dahlbom R; Blair MR
Acta Pharm Suec; 1972 Apr; 9(2):93-8. PubMed ID: 5030544
[No Abstract] [Full Text] [Related]
2. Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists.
Svensson U; Dahlbom R
Acta Pharm Suec; 1975; 12(3):209-14. PubMed ID: 1163240
[No Abstract] [Full Text] [Related]
3. Acetylene compounds of potential pharmacological value. XXX. Synthesis and pharmacological properties of N-(4-pyrrolidino-2-pentynyl)-substituted 2-pyrrolidone and succinimide.
Resul B; Ringdahl B; Dahlbom R
Acta Pharm Suec; 1979; 16(3):161-5. PubMed ID: 484249
[No Abstract] [Full Text] [Related]
4. Acetylene compounds of potential pharmacological value. 18. N-(t-aminoalkynyl)-substituted 2-pyrrolidones, a new series of potent oxotremorine antagonists.
Lindgren S; Lindquist A; Lindeke B; Svensson U; Karlén B; Dahlbom R
Acta Pharm Suec; 1973 Dec; 10(6):435-40. PubMed ID: 4773112
[No Abstract] [Full Text] [Related]
5. Acetylene compounds of potential pharmacological value. XXIX. Stereoselectivity of N-(1-alkyl-4-pyrrolidino-2-butynyl)-substituted 2-pyrrolidones and succinimides as oxotremorine antagonists.
Ringdahl B; Dahlbom R
Acta Pharm Suec; 1979; 16(1):13-20. PubMed ID: 452907
[No Abstract] [Full Text] [Related]
6. Acetylene compounds of potential pharmacological value. XII. Central and peripheral anticholinergic activity of t-aminoalkynyl esters of some carboxylic acids.
Dahlbom R; Erbing B; Olsson K; George R; Jenden DJ
Acta Pharm Suec; 1969 Jun; 6(3):349-58. PubMed ID: 5824849
[No Abstract] [Full Text] [Related]
7. Stereospecificity of oxotremorine antagonists.
Dahlbom R; Lindquist A; Lindgren S; Svensson U; Ringdahl B; Blair MR
Experientia; 1974 Oct; 30(10):1165-7. PubMed ID: 4435124
[No Abstract] [Full Text] [Related]
8. Acetylene compounds of potential pharmacological value. XXIII. N-(1-Methyl-5-pyrrolidino-3-pentynyl)-substituted succinimide and 2-pyrrolidone.
Lindgren S; Svensson U; Dahlbom R
Acta Pharm Suec; 1975; 12(5-6):503-6. PubMed ID: 1217504
[No Abstract] [Full Text] [Related]
9. Acetylene compounds of potential pharmacological value. XXI. Further studies on the effect of branching the intermediate chain of N-(t-aminoalkynyl)-substituted succinimides and 2-pyrrolidones.
Ringdahl B; Svensson U; Dahlbom R
Acta Pharm Suec; 1975; 12(4):297-304. PubMed ID: 1199731
[No Abstract] [Full Text] [Related]
10. N-(perhydroazepinoalkynyl)- and N-(perhydroazocinoalkynyl) succinimides as oxotremorine antagonists.
Lindqvist A; Lindgren S; Lindeke B; Karlén B; Dahlbom R; Blair MR
J Pharm Pharmacol; 1970 Sep; 22(9):707-8. PubMed ID: 4395168
[No Abstract] [Full Text] [Related]
11. Acetylene compounds of potential pharmacological value. IX. N-(4-dialkylamino-2-butynyl)-substituted carboxylic and sulphonic acid amides.
Dahlbom R; Karlén B; Lindquist A; George R; Jenden DJ
Acta Pharm Suec; 1967 Sep; 4(4):247-52. PubMed ID: 6082975
[No Abstract] [Full Text] [Related]
12. Central and peripheral actions of the acetylcholine antagonist, ambutonium bromide.
Southgate PJ
Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):376-82. PubMed ID: 4401084
[No Abstract] [Full Text] [Related]
13. Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF).
Plotnikoff NP; Kastin AJ; Anderson MS; Schally AV
Proc Soc Exp Biol Med; 1972 Jul; 140(3):811-4. PubMed ID: 5064701
[No Abstract] [Full Text] [Related]
14. Cyclopropane analogues to acetylenic oxotremorine antagonists.
Grundström K; Dahlbom R
Acta Pharm Suec; 1972 Nov; 9(5):491-8. PubMed ID: 4650125
[No Abstract] [Full Text] [Related]
15. The interaction of hemicholinium-3 and oxotremorine in isolated organ preparations.
György L; Pfeifer AK; Kenyeres J
J Pharm Pharmacol; 1970 Feb; 22(2):96-100. PubMed ID: 4392263
[No Abstract] [Full Text] [Related]
16. The peripheral and central actions of some anticholinergic substances.
Brimblecombe RW; Green DM
Int J Neuropharmacol; 1968 Jan; 7(1):15-21. PubMed ID: 5639303
[No Abstract] [Full Text] [Related]
17. Acetylene compounds of potential pharmacological value. XXII. Base strength and biological activity in oxotremorine antagonists.
Svensson U; Ringdahl B; Dahlbom R
Acta Pharm Suec; 1975; 12(5-6):393-400. PubMed ID: 1217491
[No Abstract] [Full Text] [Related]
18. Acetylene compounds of potential pharmacological value. XIV. N-(t-aminoalkynyl)-substituted succinimides and maleimides. A class of central anticholinergic agents.
Karlèn B; Lindeke B; Lindgren S; Svensson KG; Dahlbom R; Jenden DJ; Giering JE
J Med Chem; 1970 Jul; 13(4):651-7. PubMed ID: 5452427
[No Abstract] [Full Text] [Related]
19. Potential antiparkinsonism agents. Quinuclidinyl benzhydryl ethers.
Nilsson JL; Wågermark J; Dahlbom R
J Med Chem; 1969 Nov; 12(6):1103-5. PubMed ID: 4390829
[No Abstract] [Full Text] [Related]
20. The role of distribution as a determinant of central anticholinergic specificity in a series of oxotremorine analogs.
Karlén B; Jenden DJ
Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):471-8. PubMed ID: 5524258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
